Business, energy, technology, markets and global industry news from Business News Today

BosSTENT

PharmaDeviceNews BosSTENT
Generative artificial intelligence is reshaping medical software by moving beyond fixed predictions toward conversational clinical support, data synthesis and increasingly autonomous decision-making, raising new questions over how the FDA should evaluate AI-powered medical devices. Representative image.
Medical Devices & Diagnostics

Sonorous BosSTENT study tests brain-vein stenting for debilitating pulsatile tinnitus

Sonorous Neurovascular has expanded its B-SILENT study into Toronto, testing the investigational BosSTENT in patients with severe pulse-synchronous tinnitus caused by cerebral venous sinus stenosis.

Read More
Representative image of a neurovascular catheter procedure, reflecting Sonorous Neurovascular’s FDA-cleared BosCATH device and its role in complex cerebral venous and arterial interventions.
Medical Devices & Diagnostics

Why Sonorous Neurovascular’s BosCATH FDA clearance could matter more than it first appears

Find out how Sonorous Neurovascular’s BosCATH FDA clearance strengthens its neurovascular access strategy today!

Read More